Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.
Kluiver TA, Lu Y, Schubert SA, Kraaier LJ, Ringnalda F, Lijnzaad P, DeMartino J, Megchelenbrink WL, Amo-Addae V, Eising S, de Faria FW, Münter D, van de Wetering M, Kerl K, Duiker E, van den Heuvel MC, de Meijer VE, de Kleine RH, Molenaar JJ, Margaritis T, Stunnenberg HG, de Krijger RR, Zsiros J, Clevers H, Peng WC. Kluiver TA, et al. Among authors: megchelenbrink wl. Nat Commun. 2024 Nov 20;15(1):8576. doi: 10.1038/s41467-024-52757-w. Nat Commun. 2024. PMID: 39567475 Free PMC article.
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer.
Papulino C, Chianese U, Ali A, Favale G, Tuccillo C, Ciardiello F, Di Mauro A, Mignogna C, Ferrara G, Budillon A, Megchelenbrink WL, Del Gaudio N, Conte M, Merciai F, Campiglia P, Altucci L, Carafa V, Sommella E, Benedetti R. Papulino C, et al. Among authors: megchelenbrink wl. J Transl Med. 2024 Jul 24;22(1):676. doi: 10.1186/s12967-024-05517-9. J Transl Med. 2024. PMID: 39044184 Free PMC article.
The m6A-independent role of epitranscriptomic factors in cancer.
Bove G, Crepaldi M, Amin S, Megchelenbrink WL, Nebbioso A, Carafa V, Altucci L, Del Gaudio N. Bove G, et al. Among authors: megchelenbrink wl. Int J Cancer. 2024 Nov 15;155(10):1705-1713. doi: 10.1002/ijc.35067. Epub 2024 Jun 27. Int J Cancer. 2024. PMID: 38935523 Review.
Deregulation of New Cell Death Mechanisms in Leukemia.
Favale G, Donnarumma F, Capone V, Della Torre L, Beato A, Carannante D, Verrilli G, Nawaz A, Grimaldi F, De Simone MC, Del Gaudio N, Megchelenbrink WL, Caraglia M, Benedetti R, Altucci L, Carafa V. Favale G, et al. Among authors: megchelenbrink wl. Cancers (Basel). 2024 Apr 25;16(9):1657. doi: 10.3390/cancers16091657. Cancers (Basel). 2024. PMID: 38730609 Free PMC article. Review.
Cancer Therapy Resistance: Choosing Kinase Inhibitors.
Dell'Aversana C, Sarno F, Benedetti R, Megchelenbrink WL, Cappetta D. Dell'Aversana C, et al. Among authors: megchelenbrink wl. Pharmaceutics. 2024 Mar 7;16(3):373. doi: 10.3390/pharmaceutics16030373. Pharmaceutics. 2024. PMID: 38543267 Free PMC article.
Involvement of regulated cell deaths in aging and age-related pathologies.
Della Torre L, Beato A, Capone V, Carannante D, Verrilli G, Favale G, Del Gaudio N, Megchelenbrink WL, Benedetti R, Altucci L, Carafa V. Della Torre L, et al. Among authors: megchelenbrink wl. Ageing Res Rev. 2024 Mar;95:102251. doi: 10.1016/j.arr.2024.102251. Epub 2024 Feb 28. Ageing Res Rev. 2024. PMID: 38428821 Free article. Review.
Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme.
Jentho E, Ruiz-Moreno C, Novakovic B, Kourtzelis I, Megchelenbrink WL, Martins R, Chavakis T, Soares MP, Kalafati L, Guerra J, Roestel F, Bohm P, Godmann M, Grinenko T, Eugster A, Beretta M, Joosten LAB, Netea MG, Bauer M, Stunnenberg HG, Weis S. Jentho E, et al. Among authors: megchelenbrink wl. Proc Natl Acad Sci U S A. 2021 Oct 19;118(42):e2102698118. doi: 10.1073/pnas.2102698118. Proc Natl Acad Sci U S A. 2021. PMID: 34663697 Free PMC article.